Health Sciences (HSAC) Releases Shareholder Vote Results
Dec 17, 2019 INTEL by Kristi Marvin
Health Sciences Acquisition Corp. (HSAC), filed an 8-K this afternoon detailing the results of their recent shareholder vote to approve their business combination with Immunovant Sciences, Ltd., a clinical-stage biopharmaceutical company focused on autoimmune diseases.
As you can see below, shareholders overwhelming approved this transaction. No word yet on a closing date or new symbols, but it is expected that will be released shortly.
Unfortunately, we’ll have to wait for additional details, such as the number of redemptions, which should be filed in a later 8-K. An supplemental update will be provide once that information becomes available.